Credit: Caleb Woods on Unsplash. Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a ...

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and Drug Administration (FDA) approval as a replacement therapy for ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

but nurses and pharmacists also had the authority to order vancomycin based on oral or written orders. Exclusion criteria included patients receiving vancomycin for surgical prophylaxis ...

Shares of Marksans Pharma Ltd gained on Friday, May 30, after the company said its subsidiary secured marketing authorisation from the UK regulator for its oral solution used for treating high blood ...

Periprosthetic joint infection is a devastating complication following total joint arthroplasty and is associated with marked ...

KHINDIVI is the first and only FDA-approved hydrocortisone oral solution• Commercial launch expected the week of June 2nd• Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

KHINDIVI is the only FDA-approved oral solution formulation of hydrocortisone. It comes in a 1mg/ml strength designed to eliminate the need to split or crush tablets, and to offer simple and ...